vs
Side-by-side financial comparison of ABEONA THERAPEUTICS INC. (ABEO) and NOVO NORDISK A S (NVO). Click either name above to swap in a different company.
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel gene and cell therapies for life-threatening rare genetic diseases. Its pipeline addresses unmet medical needs, serving patient populations across North America and European markets with limited treatment alternatives.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $0 | — | ||
| Q2 25 | $400.0K | — |
| Q3 25 | $-5.2M | — | ||
| Q2 25 | $108.8M | — |
| Q3 25 | — | — | ||
| Q2 25 | -5698.0% | — |
| Q3 25 | — | — | ||
| Q2 25 | 27208.3% | — |
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $1.71 | — |
